Heath DiMaggio

Preview from Europe: Stocks Log Worst January Ever

I still think Healthcare is a good bet. No matter who's in office, people, businesses and Government will spend to make us healthy. We will work harder when were healthy and pay more taxes. Milestone Scientific (MLSS) looks like a good bet for a small health products company. It has a good sales force and a new and existing product line. The dental single tooth anesthisia makes sense. How many dentists are there in The country and elsewhere? Plus, they still have existing intstruments (products) to sell.

Gilead Sciences: Great Quarter, Strong Anti-Viral Franchise Make It a Buy

I still think Healthcare is a good bet. No matter who's in office, people, businesses and Government will spend to make us healthy. We will work harder when were healthy and pay more taxes. Milestone Scientific (MLSS) looks like a good bet for a small health products company. It has a good sales force and a new and existing product line. The dental single tooth anesthisia makes sense. How many dentists are there in The country and elsewhere? Plus, they still have existing intstruments (products) to sell.

Why the Drop in Roche's Genentech Bid?

I still think Healthcare is a good bet. No matter who's in office, people, businesses and Government will spend to make us healthy. We will work harder when were healthy and pay more taxes. Milestone Scientific (MLSS) looks like a good bet for a small health products company. It has a good sales force and a new and existing product line. The dental single tooth anesthisia makes sense. How many dentists are there in The country and elsewhere? Plus, they still have existing intstruments (products) to sell.

January Market Review: Political Transition, Bear Reignition

I still think Healthcare is a good bet. No matter who's in office, people, businesses and Government will spend to make us healthy. We will work harder when were healthy and pay more taxes. Milestone Scientific MLSS looks like a good bet for a small health products company. It has a good sales force and a new and existing product line. The dental single tooth anesthisia makes sense. How many dentists are there in The country and elsewhere? Plus, they still have existing intstruments (products) to sell.

Stem Cell Research Stocks Soar as Obama Takes Office

(ASTM) Aastrom Biosciences has been developing stem cells the non-embryonic kind for years. They have several procedures and usages they are starting to put in place. They are worth a close look at.